ReP USP - Resultado da busca

Artigo de periodico
Potential cannabidiol (CBD) repurposing as antibacterial and promising therapy of CBD plus polymyxin B (PB) against PB-resistant gram-negative bacilli (2022)
Abichabki, Nathália de Lima Martins ; Zacharias, Luísa Vieira; Moreira, Natália Columbaro; Bellíssimo-Rodrigues, Fernando; Moreira, Fernanda L.; Benzi, Jhohann Richard de Lima ; Ogasawara, Tânia Mara Casare; Ferreira, Joseane Cristina; Ribeiro, Camila M.; Pavan, Fernando R.; Pereira, Leonardo Régis Leira; Brancini, Guilherme Thomaz Pereira; Braga, Gilberto Ubida Leite; Zuardi, Antonio Waldo; Hallak, Jaime Eduardo Cecilio ; Crippa, José Alexandre de Souza ; Lanchote, Vera Lucia ; Cantón, Rafael; Darini, Ana Lúcia da Costa ; Andrade, Leonardo Neves de
Source: Scientific Reports. Unidades: FMRP, FCFRP
Subjects: CANABINOIDES, REPOSICIONAMENTO DE FÁRMACOS, RESISTÊNCIA MICROBIANA ÀS DROGAS, SINERGISMO DE DROGAS, TESTES DE SENSIBILIDADE MICROBIANA, BACTÉRIAS GRAM-NEGATIVAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ABICHABKI, Nathália de Lima Martins et al. Potential cannabidiol (CBD) repurposing as antibacterial and promising therapy of CBD plus polymyxin B (PB) against PB-resistant gram-negative bacilli. Scientific Reports, v. 12, p. 1-15, 2022Tradução . . Disponível em: https://doi.org/10.1038/s41598-022-10393-8. Acesso em: 16 nov. 2024.
APA
Abichabki, N. de L. M., Zacharias, L. V., Moreira, N. C., Bellíssimo-Rodrigues, F., Moreira, F. L., Benzi, J. R. de L., et al. (2022). Potential cannabidiol (CBD) repurposing as antibacterial and promising therapy of CBD plus polymyxin B (PB) against PB-resistant gram-negative bacilli. Scientific Reports, 12, 1-15. doi:10.1038/s41598-022-10393-8
NLM
Abichabki N de LM, Zacharias LV, Moreira NC, Bellíssimo-Rodrigues F, Moreira FL, Benzi JR de L, Ogasawara TMC, Ferreira JC, Ribeiro CM, Pavan FR, Pereira LRL, Brancini GTP, Braga GUL, Zuardi AW, Hallak JEC, Crippa JA de S, Lanchote VL, Cantón R, Darini AL da C, Andrade LN de. Potential cannabidiol (CBD) repurposing as antibacterial and promising therapy of CBD plus polymyxin B (PB) against PB-resistant gram-negative bacilli [Internet]. Scientific Reports. 2022 ; 12 1-15.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1038/s41598-022-10393-8
Vancouver
Abichabki N de LM, Zacharias LV, Moreira NC, Bellíssimo-Rodrigues F, Moreira FL, Benzi JR de L, Ogasawara TMC, Ferreira JC, Ribeiro CM, Pavan FR, Pereira LRL, Brancini GTP, Braga GUL, Zuardi AW, Hallak JEC, Crippa JA de S, Lanchote VL, Cantón R, Darini AL da C, Andrade LN de. Potential cannabidiol (CBD) repurposing as antibacterial and promising therapy of CBD plus polymyxin B (PB) against PB-resistant gram-negative bacilli [Internet]. Scientific Reports. 2022 ; 12 1-15.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1038/s41598-022-10393-8
Artigo de periodico
A background subtraction approach for determination of endogenous cortisol and 6β-hydroxycortisol in urine by UPLC-MS/MS with application in a within-day variability study in HIV-infected pregnant women (2020)
Benzi, Jhohann Richard de Lima ; Moreira, Fernanda de Lima; Marques, Maria Paula ; Duarte, Geraldo; Suarez-Kurtz, Guilherme; Lanchote, Vera Lucia
Source: Journal of Chromatography B. Unidades: FCFRP, FMRP
Subjects: LÍQUIDOS CORPORAIS, CROMATOGRAFIA LÍQUIDA DE ALTA PRESSÃO, CITOCROMO P-450, INFECÇÕES POR HIV, CORTISOL, ESPECTROMETRIA DE MASSAS, FENÓTIPOS, GRAVIDEZ
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BENZI, Jhohann Richard de Lima et al. A background subtraction approach for determination of endogenous cortisol and 6β-hydroxycortisol in urine by UPLC-MS/MS with application in a within-day variability study in HIV-infected pregnant women. Journal of Chromatography B, v. 1144 , 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jchromb.2020.122074. Acesso em: 16 nov. 2024.
APA
Benzi, J. R. de L., Moreira, F. de L., Marques, M. P., Duarte, G., Suarez-Kurtz, G., & Lanchote, V. L. (2020). A background subtraction approach for determination of endogenous cortisol and 6β-hydroxycortisol in urine by UPLC-MS/MS with application in a within-day variability study in HIV-infected pregnant women. Journal of Chromatography B, 1144 . doi:10.1016/j.jchromb.2020.122074
NLM
Benzi JR de L, Moreira F de L, Marques MP, Duarte G, Suarez-Kurtz G, Lanchote VL. A background subtraction approach for determination of endogenous cortisol and 6β-hydroxycortisol in urine by UPLC-MS/MS with application in a within-day variability study in HIV-infected pregnant women [Internet]. Journal of Chromatography B. 2020 ; 1144 [citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.jchromb.2020.122074
Vancouver
Benzi JR de L, Moreira F de L, Marques MP, Duarte G, Suarez-Kurtz G, Lanchote VL. A background subtraction approach for determination of endogenous cortisol and 6β-hydroxycortisol in urine by UPLC-MS/MS with application in a within-day variability study in HIV-infected pregnant women [Internet]. Journal of Chromatography B. 2020 ; 1144 [citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.jchromb.2020.122074
Artigo de periodico
Analysis of bupivacaine enantiomers in plasma as total and unbound concentrations using LC-MS/MS:: application in a pharmacokinetic study of a parturient with placental transfer (2019)
Souza, Marília Cristina Oliveira; Marques, Maria Paula; Duarte, Geraldo; Lanchote, Vera Lúcia
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidades: FMRP, FCFRP
Assunto: ANTIDEPRESSIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Marília Cristina Oliveira et al. Analysis of bupivacaine enantiomers in plasma as total and unbound concentrations using LC-MS/MS:: application in a pharmacokinetic study of a parturient with placental transfer. Journal of Pharmaceutical and Biomedical Analysis, v. 164, p. 268-275, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2018.10.040. Acesso em: 16 nov. 2024.
APA
Souza, M. C. O., Marques, M. P., Duarte, G., & Lanchote, V. L. (2019). Analysis of bupivacaine enantiomers in plasma as total and unbound concentrations using LC-MS/MS:: application in a pharmacokinetic study of a parturient with placental transfer. Journal of Pharmaceutical and Biomedical Analysis, 164, 268-275. doi:10.1016/j.jpba.2018.10.040
NLM
Souza MCO, Marques MP, Duarte G, Lanchote VL. Analysis of bupivacaine enantiomers in plasma as total and unbound concentrations using LC-MS/MS:: application in a pharmacokinetic study of a parturient with placental transfer [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2019 ; 164 268-275.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.jpba.2018.10.040
Vancouver
Souza MCO, Marques MP, Duarte G, Lanchote VL. Analysis of bupivacaine enantiomers in plasma as total and unbound concentrations using LC-MS/MS:: application in a pharmacokinetic study of a parturient with placental transfer [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2019 ; 164 268-275.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.jpba.2018.10.040
Artigo de periodico
Albendazole sulfoxide plasma levels and efficacy of antiparasitic treatment in patients with parenchymal neurocysticercosis (2019)
Arroyo, Gianfranco; Bustos, Javier A.; Lescano, Andres G.; Gonzales, Isidro; Saavedra, Herbert; Rodriguez, Silvia; Pretell, E. Javier; Bonato, Pierina Sueli; Lanchote, Vera Lucia ; Takayanagui, Osvaldo Massaiti ; Horton, John; Gonzalez, Armando E.; Gilman, Robert H.; Garcia, Hector H.
Source: Clinical Infectious Diseases. Unidades: FCFRP, FMRP
Subjects: NEUROCISTICERCOSE, ANTIPARASITÁRIOS, ANTI-HELMÍNTICOS, CISTOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARROYO, Gianfranco et al. Albendazole sulfoxide plasma levels and efficacy of antiparasitic treatment in patients with parenchymal neurocysticercosis. Clinical Infectious Diseases, v. 69, n. 11, p. 1996-2002, 2019Tradução . . Disponível em: https://doi.org/10.1093/cid/ciz085. Acesso em: 16 nov. 2024.
APA
Arroyo, G., Bustos, J. A., Lescano, A. G., Gonzales, I., Saavedra, H., Rodriguez, S., et al. (2019). Albendazole sulfoxide plasma levels and efficacy of antiparasitic treatment in patients with parenchymal neurocysticercosis. Clinical Infectious Diseases, 69( 11), 1996-2002. doi:10.1093/cid/ciz085
NLM
Arroyo G, Bustos JA, Lescano AG, Gonzales I, Saavedra H, Rodriguez S, Pretell EJ, Bonato PS, Lanchote VL, Takayanagui OM, Horton J, Gonzalez AE, Gilman RH, Garcia HH. Albendazole sulfoxide plasma levels and efficacy of antiparasitic treatment in patients with parenchymal neurocysticercosis [Internet]. Clinical Infectious Diseases. 2019 ; 69( 11): 1996-2002.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1093/cid/ciz085
Vancouver
Arroyo G, Bustos JA, Lescano AG, Gonzales I, Saavedra H, Rodriguez S, Pretell EJ, Bonato PS, Lanchote VL, Takayanagui OM, Horton J, Gonzalez AE, Gilman RH, Garcia HH. Albendazole sulfoxide plasma levels and efficacy of antiparasitic treatment in patients with parenchymal neurocysticercosis [Internet]. Clinical Infectious Diseases. 2019 ; 69( 11): 1996-2002.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1093/cid/ciz085
Artigo de periodico
Evaluation of potential herbal-drug interactions of a standardized propolis extract (EPP-AF®) using an in vivo cocktail approach (2019)
Cusinato, Diego Alberto Ciscato ; Martinez, Edson Zangiacomi ; Cintra, Mônica T. C.; Filgueira, Gabriela Campos de Oliveira ; Berretta, Andresa A.; Lanchote, Vera Lucia ; Coelho, Eduardo Barbosa
Source: Journal of Ethnopharmacology. Unidades: FMRP, FCFRP
Subjects: PRÓPOLIS, FÁRMACOS DE ORIGEM ANIMAL, METABOLISMO, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CUSINATO, Diego Alberto Ciscato et al. Evaluation of potential herbal-drug interactions of a standardized propolis extract (EPP-AF®) using an in vivo cocktail approach. Journal of Ethnopharmacology, v. 245, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.jep.2019.112174. Acesso em: 16 nov. 2024.
APA
Cusinato, D. A. C., Martinez, E. Z., Cintra, M. T. C., Filgueira, G. C. de O., Berretta, A. A., Lanchote, V. L., & Coelho, E. B. (2019). Evaluation of potential herbal-drug interactions of a standardized propolis extract (EPP-AF®) using an in vivo cocktail approach. Journal of Ethnopharmacology, 245. doi:10.1016/j.jep.2019.112174
NLM
Cusinato DAC, Martinez EZ, Cintra MTC, Filgueira GC de O, Berretta AA, Lanchote VL, Coelho EB. Evaluation of potential herbal-drug interactions of a standardized propolis extract (EPP-AF®) using an in vivo cocktail approach [Internet]. Journal of Ethnopharmacology. 2019 ; 245[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.jep.2019.112174
Vancouver
Cusinato DAC, Martinez EZ, Cintra MTC, Filgueira GC de O, Berretta AA, Lanchote VL, Coelho EB. Evaluation of potential herbal-drug interactions of a standardized propolis extract (EPP-AF®) using an in vivo cocktail approach [Internet]. Journal of Ethnopharmacology. 2019 ; 245[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.jep.2019.112174
Artigo de periodico
Analysis of unbound plasma concentration of oxcarbazepine and the 10-hydroxycarbazepine enantiomers by liquid chromatography with tandem mass spectrometry in healthy volunteers (2018)
Antunes, Natalícia de Jesus; Wichert-Ana, Lauro ; Coelho, Eduardo Barbosa ; Della Pasqua, Oscar; Alexandre Júnior, Veriano; Takayanagui, Osvaldo Massaiti ; Marques, Maria Paula ; Lanchote, Vera Lucia
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidades: FMRP, FCFRP
Subjects: ANTICONVULSIVANTES, FARMACOCINÉTICA, ESPECTROMETRIA DE MASSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANTUNES, Natalícia de Jesus et al. Analysis of unbound plasma concentration of oxcarbazepine and the 10-hydroxycarbazepine enantiomers by liquid chromatography with tandem mass spectrometry in healthy volunteers. Journal of Pharmaceutical and Biomedical Analysis, v. 149, p. 442-447, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2017.11.041. Acesso em: 16 nov. 2024.
APA
Antunes, N. de J., Wichert-Ana, L., Coelho, E. B., Della Pasqua, O., Alexandre Júnior, V., Takayanagui, O. M., et al. (2018). Analysis of unbound plasma concentration of oxcarbazepine and the 10-hydroxycarbazepine enantiomers by liquid chromatography with tandem mass spectrometry in healthy volunteers. Journal of Pharmaceutical and Biomedical Analysis, 149, 442-447. doi:10.1016/j.jpba.2017.11.041
NLM
Antunes N de J, Wichert-Ana L, Coelho EB, Della Pasqua O, Alexandre Júnior V, Takayanagui OM, Marques MP, Lanchote VL. Analysis of unbound plasma concentration of oxcarbazepine and the 10-hydroxycarbazepine enantiomers by liquid chromatography with tandem mass spectrometry in healthy volunteers [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2018 ; 149 442-447.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.jpba.2017.11.041
Vancouver
Antunes N de J, Wichert-Ana L, Coelho EB, Della Pasqua O, Alexandre Júnior V, Takayanagui OM, Marques MP, Lanchote VL. Analysis of unbound plasma concentration of oxcarbazepine and the 10-hydroxycarbazepine enantiomers by liquid chromatography with tandem mass spectrometry in healthy volunteers [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2018 ; 149 442-447.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.jpba.2017.11.041
Artigo de periodico
Enantioselectivity in the metabolism of cyclophosphamide in patients with multiple or systemic sclerosis (2017)
Castro, Francine Attié de; Simões, Belinda Pinto; Coelho, Eduardo Barbosa; Lanchote, Vera Lúcia
Source: The Journal of Clinical Pharmacology. Unidades: FMRP, FCFRP
Subjects: CITOCINAS, FÁRMACOS IMUNOSSUPRESSORES, ESCLEROSE MÚLTIPLA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO, Francine Attié de et al. Enantioselectivity in the metabolism of cyclophosphamide in patients with multiple or systemic sclerosis. The Journal of Clinical Pharmacology, v. 57, n. 6, p. 784-795, 2017Tradução . . Disponível em: https://doi.org/10.1002/jcph.863. Acesso em: 16 nov. 2024.
APA
Castro, F. A. de, Simões, B. P., Coelho, E. B., & Lanchote, V. L. (2017). Enantioselectivity in the metabolism of cyclophosphamide in patients with multiple or systemic sclerosis. The Journal of Clinical Pharmacology, 57( 6), 784-795. doi:10.1002/jcph.863
NLM
Castro FA de, Simões BP, Coelho EB, Lanchote VL. Enantioselectivity in the metabolism of cyclophosphamide in patients with multiple or systemic sclerosis [Internet]. The Journal of Clinical Pharmacology. 2017 ; 57( 6): 784-795.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1002/jcph.863
Vancouver
Castro FA de, Simões BP, Coelho EB, Lanchote VL. Enantioselectivity in the metabolism of cyclophosphamide in patients with multiple or systemic sclerosis [Internet]. The Journal of Clinical Pharmacology. 2017 ; 57( 6): 784-795.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1002/jcph.863
Artigo de periodico
Population pharmacokinetics of carvedilol enantiomers and their metabolites in healthy subjects and type-2 diabetes patients (2017)
Nardotto, Glauco H. B; Lanchote, Vera Lúcia; Coelho, Eduardo Barbosa; Della Pasqua, Oscar
Source: European Journal of Pharmaceutical Sciences. Unidades: FCFRP, FMRP
Subjects: FARMACOLOGIA, DIABETES MELLITUS, ANTAGONISMO DE DROGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NARDOTTO, Glauco H. B et al. Population pharmacokinetics of carvedilol enantiomers and their metabolites in healthy subjects and type-2 diabetes patients. European Journal of Pharmaceutical Sciences, v. 109S, p. S108-S115, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2017.05.033. Acesso em: 16 nov. 2024.
APA
Nardotto, G. H. B., Lanchote, V. L., Coelho, E. B., & Della Pasqua, O. (2017). Population pharmacokinetics of carvedilol enantiomers and their metabolites in healthy subjects and type-2 diabetes patients. European Journal of Pharmaceutical Sciences, 109S, S108-S115. doi:10.1016/j.ejps.2017.05.033
NLM
Nardotto GHB, Lanchote VL, Coelho EB, Della Pasqua O. Population pharmacokinetics of carvedilol enantiomers and their metabolites in healthy subjects and type-2 diabetes patients [Internet]. European Journal of Pharmaceutical Sciences. 2017 ; 109S S108-S115.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.ejps.2017.05.033
Vancouver
Nardotto GHB, Lanchote VL, Coelho EB, Della Pasqua O. Population pharmacokinetics of carvedilol enantiomers and their metabolites in healthy subjects and type-2 diabetes patients [Internet]. European Journal of Pharmaceutical Sciences. 2017 ; 109S S108-S115.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.ejps.2017.05.033
Artigo de periodico
Development of an enantioselective and biomarker-informed translational population pharmacokinetic/pharmacodynamic model for etodolac (2017)
Silva, Carolina de Miranda; Rocha, Adriana; Tozatto, Eduardo; Silva, Lucienir Maria da; Donadi, Eduardo Antônio; Costa, Teresa Dalla; Lanchote, Vera Lúcia; Schmidt, Stephan; Bulitta, Jürgen B.
Source: The AAPS Journal. Unidades: FCFRP, FMRP
Subjects: FARMACODINÂMICA, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Carolina de Miranda et al. Development of an enantioselective and biomarker-informed translational population pharmacokinetic/pharmacodynamic model for etodolac. The AAPS Journal, v. 19, n. 6, p. 1814-1825, 2017Tradução . . Disponível em: https://doi.org/10.1208/s12248-017-0138-9. Acesso em: 16 nov. 2024.
APA
Silva, C. de M., Rocha, A., Tozatto, E., Silva, L. M. da, Donadi, E. A., Costa, T. D., et al. (2017). Development of an enantioselective and biomarker-informed translational population pharmacokinetic/pharmacodynamic model for etodolac. The AAPS Journal, 19( 6), 1814-1825. doi:10.1208/s12248-017-0138-9
NLM
Silva C de M, Rocha A, Tozatto E, Silva LM da, Donadi EA, Costa TD, Lanchote VL, Schmidt S, Bulitta JB. Development of an enantioselective and biomarker-informed translational population pharmacokinetic/pharmacodynamic model for etodolac [Internet]. The AAPS Journal. 2017 ; 19( 6): 1814-1825.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1208/s12248-017-0138-9
Vancouver
Silva C de M, Rocha A, Tozatto E, Silva LM da, Donadi EA, Costa TD, Lanchote VL, Schmidt S, Bulitta JB. Development of an enantioselective and biomarker-informed translational population pharmacokinetic/pharmacodynamic model for etodolac [Internet]. The AAPS Journal. 2017 ; 19( 6): 1814-1825.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1208/s12248-017-0138-9
Artigo de periodico
Effects of type 2 diabetes mellitus in patients on treatment with glibenclamide and metformin on carvedilol enantiomers metabolism (2017)
Nardotto, Glauco H. B.; Coelho, Eduardo Barbosa; Paiva, Carlos E.; Lanchote, Vera Lúcia
Source: The Journal of Clinical Pharmacology. Unidades: FMRP, FCFRP
Subjects: DIABETES MELLITUS, ANTAGONISTAS, RECEPTORES ADRENÉRGICOS, FREQUÊNCIA CARDÍACA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NARDOTTO, Glauco H. B. et al. Effects of type 2 diabetes mellitus in patients on treatment with glibenclamide and metformin on carvedilol enantiomers metabolism. The Journal of Clinical Pharmacology, v. 57, n. 6, p. 760-769, 2017Tradução . . Disponível em: https://doi.org/10.1002/jcph.864. Acesso em: 16 nov. 2024.
APA
Nardotto, G. H. B., Coelho, E. B., Paiva, C. E., & Lanchote, V. L. (2017). Effects of type 2 diabetes mellitus in patients on treatment with glibenclamide and metformin on carvedilol enantiomers metabolism. The Journal of Clinical Pharmacology, 57( 6), 760-769. doi:10.1002/jcph.864
NLM
Nardotto GHB, Coelho EB, Paiva CE, Lanchote VL. Effects of type 2 diabetes mellitus in patients on treatment with glibenclamide and metformin on carvedilol enantiomers metabolism [Internet]. The Journal of Clinical Pharmacology. 2017 ; 57( 6): 760-769.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1002/jcph.864
Vancouver
Nardotto GHB, Coelho EB, Paiva CE, Lanchote VL. Effects of type 2 diabetes mellitus in patients on treatment with glibenclamide and metformin on carvedilol enantiomers metabolism [Internet]. The Journal of Clinical Pharmacology. 2017 ; 57( 6): 760-769.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1002/jcph.864
Artigo de periodico
Population pharmacokinetics of oxcarbazepine and its metabolite 10-hydroxycarbazepine in healthy subjects (2017)
Antunes, Natalicia de Jesus; van Dijkman, Sven C.; Lanchote, Vera Lúcia; Wichert-Ana, Lauro; Coelho, Eduardo Barbosa; Alexandre Junior, Veriano; Takayanagui, Osvaldo Massaíti; Tozatto, Eduardo; van Hasselt, J.G. Coen; Della Pasqua, Oscar
Source: European Journal of Pharmaceutical Sciences. Unidades: FCFRP, FMRP
Assunto: ANTICONVULSIVANTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANTUNES, Natalicia de Jesus et al. Population pharmacokinetics of oxcarbazepine and its metabolite 10-hydroxycarbazepine in healthy subjects. European Journal of Pharmaceutical Sciences, v. 109, p. S116-S123, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2017.05.034. Acesso em: 16 nov. 2024.
APA
Antunes, N. de J., van Dijkman, S. C., Lanchote, V. L., Wichert-Ana, L., Coelho, E. B., Alexandre Junior, V., et al. (2017). Population pharmacokinetics of oxcarbazepine and its metabolite 10-hydroxycarbazepine in healthy subjects. European Journal of Pharmaceutical Sciences, 109, S116-S123. doi:10.1016/j.ejps.2017.05.034
NLM
Antunes N de J, van Dijkman SC, Lanchote VL, Wichert-Ana L, Coelho EB, Alexandre Junior V, Takayanagui OM, Tozatto E, van Hasselt JGC, Della Pasqua O. Population pharmacokinetics of oxcarbazepine and its metabolite 10-hydroxycarbazepine in healthy subjects [Internet]. European Journal of Pharmaceutical Sciences. 2017 ; 109 S116-S123.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.ejps.2017.05.034
Vancouver
Antunes N de J, van Dijkman SC, Lanchote VL, Wichert-Ana L, Coelho EB, Alexandre Junior V, Takayanagui OM, Tozatto E, van Hasselt JGC, Della Pasqua O. Population pharmacokinetics of oxcarbazepine and its metabolite 10-hydroxycarbazepine in healthy subjects [Internet]. European Journal of Pharmaceutical Sciences. 2017 ; 109 S116-S123.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.ejps.2017.05.034
Artigo de periodico
Influence of chronic kidney disease and haemodialysis treatment on pharmacokinetics of nebivolol enantiomers (2016)
Neves, Daniel V.; Lanchote, Vera Lúcia; Moysés Neto, Miguel; Costa, José Abrão Cardeal da; Vieira, Carolina P.; Coelho, Eduardo Barbosa
Source: British Journal of Clinical Pharmacology. Unidades: FCFRP, FMRP
Subjects: NEFROPATIAS, FARMACOCINÉTICA, FENÓTIPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NEVES, Daniel V. et al. Influence of chronic kidney disease and haemodialysis treatment on pharmacokinetics of nebivolol enantiomers. British Journal of Clinical Pharmacology, v. 82, n. 1, p. 83-91, 2016Tradução . . Disponível em: https://doi.org/10.1111/bcp.12917. Acesso em: 16 nov. 2024.
APA
Neves, D. V., Lanchote, V. L., Moysés Neto, M., Costa, J. A. C. da, Vieira, C. P., & Coelho, E. B. (2016). Influence of chronic kidney disease and haemodialysis treatment on pharmacokinetics of nebivolol enantiomers. British Journal of Clinical Pharmacology, 82( 1), 83-91. doi:10.1111/bcp.12917
NLM
Neves DV, Lanchote VL, Moysés Neto M, Costa JAC da, Vieira CP, Coelho EB. Influence of chronic kidney disease and haemodialysis treatment on pharmacokinetics of nebivolol enantiomers [Internet]. British Journal of Clinical Pharmacology. 2016 ; 82( 1): 83-91.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/bcp.12917
Vancouver
Neves DV, Lanchote VL, Moysés Neto M, Costa JAC da, Vieira CP, Coelho EB. Influence of chronic kidney disease and haemodialysis treatment on pharmacokinetics of nebivolol enantiomers [Internet]. British Journal of Clinical Pharmacology. 2016 ; 82( 1): 83-91.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/bcp.12917
Artigo de periodico
Analysis of nifedipine in human plasma and amniotic fluid by liquid chromatography-tandem mass spectrometry and its application to clinical pharmacokinetics in hypertensive pregnant women (2015)
Filgueira, Gabriela Campos de Oliveira; Filgueira, Osmany Alberto Silva; Carvalho, Daniela Miarelli; Marques, Maria Paula; Moisés, Elaine Christine Dantas; Duarte, Geraldo; Lanchote, Vera Lúcia; Cavalli, Ricardo de Carvalho
Source: Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. Unidades: FMRP, FCFRP
Subjects: FARMACOCINÉTICA, GRAVIDEZ, HIPERTENSÃO NA GRAVIDEZ
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FILGUEIRA, Gabriela Campos de Oliveira et al. Analysis of nifedipine in human plasma and amniotic fluid by liquid chromatography-tandem mass spectrometry and its application to clinical pharmacokinetics in hypertensive pregnant women. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, v. 993-994, p. 20-25, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.jchromb.2015.04.030. Acesso em: 16 nov. 2024.
APA
Filgueira, G. C. de O., Filgueira, O. A. S., Carvalho, D. M., Marques, M. P., Moisés, E. C. D., Duarte, G., et al. (2015). Analysis of nifedipine in human plasma and amniotic fluid by liquid chromatography-tandem mass spectrometry and its application to clinical pharmacokinetics in hypertensive pregnant women. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 993-994, 20-25. doi:10.1016/j.jchromb.2015.04.030
NLM
Filgueira GC de O, Filgueira OAS, Carvalho DM, Marques MP, Moisés ECD, Duarte G, Lanchote VL, Cavalli R de C. Analysis of nifedipine in human plasma and amniotic fluid by liquid chromatography-tandem mass spectrometry and its application to clinical pharmacokinetics in hypertensive pregnant women [Internet]. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 2015 ; 993-994 20-25.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.jchromb.2015.04.030
Vancouver
Filgueira GC de O, Filgueira OAS, Carvalho DM, Marques MP, Moisés ECD, Duarte G, Lanchote VL, Cavalli R de C. Analysis of nifedipine in human plasma and amniotic fluid by liquid chromatography-tandem mass spectrometry and its application to clinical pharmacokinetics in hypertensive pregnant women [Internet]. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 2015 ; 993-994 20-25.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.jchromb.2015.04.030
Artigo de periodico
Analysis of oxcarbazepine and the 10-hydroxycarbazepine enantiomers in plasma by LC-MS/MS: application in a pharmacokinetic study (2013)
Antunes, Natalicia de Jesus; Wichert-Ana, Lauro; Coelho, Eduardo Barbosa; Pasqua, Oscar Della; Alexandre Junior, Veriano; Takayanagui, Osvaldo Massaiti; Tozatto, Eduardo; Lanchote, Vera Lúcia
Source: Chirality. Unidades: FMRP, FCFRP
Subjects: FÁRMACOS PSICOTRÓPICOS, FARMACOCINÉTICA, CROMATOGRAFIA LÍQUIDA, ESPECTROMETRIA DE MASSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANTUNES, Natalicia de Jesus et al. Analysis of oxcarbazepine and the 10-hydroxycarbazepine enantiomers in plasma by LC-MS/MS: application in a pharmacokinetic study. Chirality, v. 25, n. 12, p. 897-903, 2013Tradução . . Disponível em: https://doi.org/10.1002/chir.22231. Acesso em: 16 nov. 2024.
APA
Antunes, N. de J., Wichert-Ana, L., Coelho, E. B., Pasqua, O. D., Alexandre Junior, V., Takayanagui, O. M., et al. (2013). Analysis of oxcarbazepine and the 10-hydroxycarbazepine enantiomers in plasma by LC-MS/MS: application in a pharmacokinetic study. Chirality, 25( 12), 897-903. doi:10.1002/chir.22231
NLM
Antunes N de J, Wichert-Ana L, Coelho EB, Pasqua OD, Alexandre Junior V, Takayanagui OM, Tozatto E, Lanchote VL. Analysis of oxcarbazepine and the 10-hydroxycarbazepine enantiomers in plasma by LC-MS/MS: application in a pharmacokinetic study [Internet]. Chirality. 2013 ; 25( 12): 897-903.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1002/chir.22231
Vancouver
Antunes N de J, Wichert-Ana L, Coelho EB, Pasqua OD, Alexandre Junior V, Takayanagui OM, Tozatto E, Lanchote VL. Analysis of oxcarbazepine and the 10-hydroxycarbazepine enantiomers in plasma by LC-MS/MS: application in a pharmacokinetic study [Internet]. Chirality. 2013 ; 25( 12): 897-903.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1002/chir.22231
Artigo de periodico
Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis (2011)
Garcia, Hector H.; Lescano, Andres G.; Lanchote, Vera Lúcia; Pretell, E. Javier; Gonzales, Isidro; Bustos, Javier A.; Takayanagui, Osvaldo Massaiti; Bonato, Pierina Sueli; Horton, John; Saavedra, Herbert; Gonzalez, Armando E.; Gilman, Robert H.
Source: British Journal of Clinical Pharmacology. Unidades: FCFRP, FMRP
Subjects: FARMACOCINÉTICA, ANTIPARASITÁRIOS, CISTICERCOSE (TRATAMENTO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GARCIA, Hector H. et al. Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis. British Journal of Clinical Pharmacology, v. 72, n. 1, p. 77-84, 2011Tradução . . Disponível em: https://doi.org/10.1111/j.1365-2125.2011.03945.x. Acesso em: 16 nov. 2024.
APA
Garcia, H. H., Lescano, A. G., Lanchote, V. L., Pretell, E. J., Gonzales, I., Bustos, J. A., et al. (2011). Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis. British Journal of Clinical Pharmacology, 72( 1), 77-84. doi:10.1111/j.1365-2125.2011.03945.x
NLM
Garcia HH, Lescano AG, Lanchote VL, Pretell EJ, Gonzales I, Bustos JA, Takayanagui OM, Bonato PS, Horton J, Saavedra H, Gonzalez AE, Gilman RH. Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis [Internet]. British Journal of Clinical Pharmacology. 2011 ; 72( 1): 77-84.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/j.1365-2125.2011.03945.x
Vancouver
Garcia HH, Lescano AG, Lanchote VL, Pretell EJ, Gonzales I, Bustos JA, Takayanagui OM, Bonato PS, Horton J, Saavedra H, Gonzalez AE, Gilman RH. Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis [Internet]. British Journal of Clinical Pharmacology. 2011 ; 72( 1): 77-84.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/j.1365-2125.2011.03945.x
Artigo de periodico
Epidural versus intravenous fentanyl for postoperative analgesia following orthopedic surgery: randomized controlled trial (2010)
Privado, Marcelo Soares; Issy, Adriana Machado; Lanchote, Vera Lúcia; Garcia, João Batista Santos; Sakata, Rioko Kimiko
Source: São Paulo Medical Journal. Unidade: FCFRP
Subjects: CIRURGIA ORTOPÉDICA, FARMACOLOGIA, ANALGESIA (COMPARAÇÃO;EFICIÊNCIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRIVADO, Marcelo Soares et al. Epidural versus intravenous fentanyl for postoperative analgesia following orthopedic surgery: randomized controlled trial. São Paulo Medical Journal, v. 128, n. 1, p. 5-9, 2010Tradução . . Disponível em: https://doi.org/10.1590/s1516-31802010000100002. Acesso em: 16 nov. 2024.
APA
Privado, M. S., Issy, A. M., Lanchote, V. L., Garcia, J. B. S., & Sakata, R. K. (2010). Epidural versus intravenous fentanyl for postoperative analgesia following orthopedic surgery: randomized controlled trial. São Paulo Medical Journal, 128( 1), 5-9. doi:10.1590/s1516-31802010000100002
NLM
Privado MS, Issy AM, Lanchote VL, Garcia JBS, Sakata RK. Epidural versus intravenous fentanyl for postoperative analgesia following orthopedic surgery: randomized controlled trial [Internet]. São Paulo Medical Journal. 2010 ; 128( 1): 5-9.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1590/s1516-31802010000100002
Vancouver
Privado MS, Issy AM, Lanchote VL, Garcia JBS, Sakata RK. Epidural versus intravenous fentanyl for postoperative analgesia following orthopedic surgery: randomized controlled trial [Internet]. São Paulo Medical Journal. 2010 ; 128( 1): 5-9.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1590/s1516-31802010000100002
Artigo de periodico
Determination of cyclophosphamide enantiomers in plasma by LC-MS/MS: application to pharmacokinetics in breast cancer and lupus nephritis patients (2009)
Silva, Carolina de Miranda; Fernandes, Bruno José Dumêt; Pereira, Maria Paula Marques; Silva, Lucienir Maria da; Donadi, Eduardo Antônio; Matthes, Ângelo do Carmo Silva; Andrade, Jurandyr Moreira de; Lanchote, Vera Lúcia
Source: Chirality. Unidades: FCFRP, FMRP
Subjects: NEOPLASIAS MAMÁRIAS, FARMACOTÉCNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Carolina de Miranda et al. Determination of cyclophosphamide enantiomers in plasma by LC-MS/MS: application to pharmacokinetics in breast cancer and lupus nephritis patients. Chirality, v. 21, n. 3, p. 383-389, 2009Tradução . . Disponível em: https://doi.org/10.1002/chir.20596. Acesso em: 16 nov. 2024.
APA
Silva, C. de M., Fernandes, B. J. D., Pereira, M. P. M., Silva, L. M. da, Donadi, E. A., Matthes, Â. do C. S., et al. (2009). Determination of cyclophosphamide enantiomers in plasma by LC-MS/MS: application to pharmacokinetics in breast cancer and lupus nephritis patients. Chirality, 21( 3), 383-389. doi:10.1002/chir.20596
NLM
Silva C de M, Fernandes BJD, Pereira MPM, Silva LM da, Donadi EA, Matthes Â do CS, Andrade JM de, Lanchote VL. Determination of cyclophosphamide enantiomers in plasma by LC-MS/MS: application to pharmacokinetics in breast cancer and lupus nephritis patients [Internet]. Chirality. 2009 ; 21( 3): 383-389.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1002/chir.20596
Vancouver
Silva C de M, Fernandes BJD, Pereira MPM, Silva LM da, Donadi EA, Matthes Â do CS, Andrade JM de, Lanchote VL. Determination of cyclophosphamide enantiomers in plasma by LC-MS/MS: application to pharmacokinetics in breast cancer and lupus nephritis patients [Internet]. Chirality. 2009 ; 21( 3): 383-389.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1002/chir.20596
Artigo de periodico
Influence of quinidine, cimetidine, and ketoconazole on the enantioselective pharmacokinetics and metabolism of metoprolol in rats (2009)
Boralli, Vanessa Bergamin; Coelho, Eduardo Barbosa; Lanchote, Vera Lúcia
Source: Chirality. Unidades: FMRP, FCFRP
Subjects: METABÓLITOS, FARMACOCINÉTICA, HIPERTENSÃO (TRATAMENTO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORALLI, Vanessa Bergamin e COELHO, Eduardo Barbosa e LANCHOTE, Vera Lúcia. Influence of quinidine, cimetidine, and ketoconazole on the enantioselective pharmacokinetics and metabolism of metoprolol in rats. Chirality, v. 21, n. 10, p. 886-893, 2009Tradução . . Disponível em: https://doi.org/10.1002/chir.20682. Acesso em: 16 nov. 2024.
APA
Boralli, V. B., Coelho, E. B., & Lanchote, V. L. (2009). Influence of quinidine, cimetidine, and ketoconazole on the enantioselective pharmacokinetics and metabolism of metoprolol in rats. Chirality, 21( 10), 886-893. doi:10.1002/chir.20682
NLM
Boralli VB, Coelho EB, Lanchote VL. Influence of quinidine, cimetidine, and ketoconazole on the enantioselective pharmacokinetics and metabolism of metoprolol in rats [Internet]. Chirality. 2009 ; 21( 10): 886-893.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1002/chir.20682
Vancouver
Boralli VB, Coelho EB, Lanchote VL. Influence of quinidine, cimetidine, and ketoconazole on the enantioselective pharmacokinetics and metabolism of metoprolol in rats [Internet]. Chirality. 2009 ; 21( 10): 886-893.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1002/chir.20682
Artigo de periodico
Enantioselective analysis of praziquantel and trans-4-hydroxypraziquantel in human plasma by chiral LC-MS/MS: application to pharmacokinetics (2009)
Lima, Renata Monteiro; Ferreira, Maria Augusta Drago; Ponte, Teresa Maria de Jesus; Marques, Maria Paula; Takayanagui, Osvaldo Massaiti; Garcia, Hector Hugo; Coelho, Eduardo Barbosa; Bonato, Pierina Sueli; Lanchote, Vera Lúcia
Source: Journal of Chromatography B. Unidades: FMRP, FCFRP
Subjects: FARMACOCINÉTICA, METABOLISMO, PLASMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Renata Monteiro et al. Enantioselective analysis of praziquantel and trans-4-hydroxypraziquantel in human plasma by chiral LC-MS/MS: application to pharmacokinetics. Journal of Chromatography B, v. 877, n. 27, p. 3083-3088, 2009Tradução . . Disponível em: https://doi.org/10.1016/j.jchromb.2009.07.036. Acesso em: 16 nov. 2024.
APA
Lima, R. M., Ferreira, M. A. D., Ponte, T. M. de J., Marques, M. P., Takayanagui, O. M., Garcia, H. H., et al. (2009). Enantioselective analysis of praziquantel and trans-4-hydroxypraziquantel in human plasma by chiral LC-MS/MS: application to pharmacokinetics. Journal of Chromatography B, 877( 27), 3083-3088. doi:10.1016/j.jchromb.2009.07.036
NLM
Lima RM, Ferreira MAD, Ponte TM de J, Marques MP, Takayanagui OM, Garcia HH, Coelho EB, Bonato PS, Lanchote VL. Enantioselective analysis of praziquantel and trans-4-hydroxypraziquantel in human plasma by chiral LC-MS/MS: application to pharmacokinetics [Internet]. Journal of Chromatography B. 2009 ; 877( 27): 3083-3088.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.jchromb.2009.07.036
Vancouver
Lima RM, Ferreira MAD, Ponte TM de J, Marques MP, Takayanagui OM, Garcia HH, Coelho EB, Bonato PS, Lanchote VL. Enantioselective analysis of praziquantel and trans-4-hydroxypraziquantel in human plasma by chiral LC-MS/MS: application to pharmacokinetics [Internet]. Journal of Chromatography B. 2009 ; 877( 27): 3083-3088.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.jchromb.2009.07.036
Artigo de periodico
Stereoselective analysis of carvedilol in human plasma and urine using HPLC after chiral derivatization (2008)
Peccinini, Rosângela G.; Ximenes, Valdecir F.; Cesarino, Evandro José; Lanchote, Vera Lúcia
Source: Biopharmaceutics & Drug Disposition. Unidade: FCFRP
Subjects: FARMACOCINÉTICA, PLASMA, CROMATOGRAFIA LÍQUIDA DE ALTA EFICIÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PECCININI, Rosângela G. et al. Stereoselective analysis of carvedilol in human plasma and urine using HPLC after chiral derivatization. Biopharmaceutics & Drug Disposition, v. 29, n. 5, p. 280-288, 2008Tradução . . Disponível em: https://doi.org/10.1002/bdd.613. Acesso em: 16 nov. 2024.
APA
Peccinini, R. G., Ximenes, V. F., Cesarino, E. J., & Lanchote, V. L. (2008). Stereoselective analysis of carvedilol in human plasma and urine using HPLC after chiral derivatization. Biopharmaceutics & Drug Disposition, 29( 5), 280-288. doi:10.1002/bdd.613
NLM
Peccinini RG, Ximenes VF, Cesarino EJ, Lanchote VL. Stereoselective analysis of carvedilol in human plasma and urine using HPLC after chiral derivatization [Internet]. Biopharmaceutics & Drug Disposition. 2008 ; 29( 5): 280-288.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1002/bdd.613
Vancouver
Peccinini RG, Ximenes VF, Cesarino EJ, Lanchote VL. Stereoselective analysis of carvedilol in human plasma and urine using HPLC after chiral derivatization [Internet]. Biopharmaceutics & Drug Disposition. 2008 ; 29( 5): 280-288.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1002/bdd.613

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Countries/Territories

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration